| Identification | Back Directory | [Name]
2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- | [CAS]
2396664-85-8 | [Synonyms]
FGFR4-IN-11 2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- | [Molecular Formula]
C29H29N5O5 | [MOL File]
2396664-85-8.mol | [Molecular Weight]
527.57 |
| Hazard Information | Back Directory | [Uses]
FGFR4-IN-11 (Compound 30) is a potent, selective, covalent FGFR4 inhibitor with an IC50 of 2.1 nM. FGFR4-IN-11 significantly inhibits the FGF19/FGFR4 signaling pathway and shows antitumor activity[1]. | [IC 50]
FGFR4: 2.1 nM (IC50) | [References]
[1] Zhong Z, et al. Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma. J Med Chem. 2022 May 26;65(10):7278-7295. DOI:10.1021/acs.jmedchem.2c00255 |
|
|